Current Use and Developments Needed for Optimal Design in Pharmacometrics: A Study Performed Among DDMoRe's European Federation of Pharmaceutical Industries and Associations Member...

por Mentré, F, Chenel, M, Comets, E, Grevel, J, Hooker, A, Karlsson, M O, Lavielle, M, Gueorguieva, I
Publicado 2013

White Paper: Landscape on Technical and Conceptual Requirements and Competence Framework in Drug/Disease Modeling and Simulation

por Vlasakakis, G, Comets, E, Keunecke, A, Gueorguieva, I, Magni, P, Terranova, N, Della Pasqua, O, de Lange, E C, Kloft, C
Publicado 2013

A Review of Mixed-Effects Models of Tumor Growth and Effects of Anticancer Drug Treatment Used in Population Analysis

por Ribba, B, Holford, N H, Magni, P, Trocóniz, I, Gueorguieva, I, Girard, P, Sarr, C, Elishmereni, M, Kloft, C, Friberg, L E
Publicado 2014

A Phase 2 Study of Galunisertib (TGF-β1 Receptor Type I Inhibitor) and Sorafenib in Patients With Advanced Hepatocellular Carcinoma

por Kelley, R.K., Gane, E., Assenat, E., Siebler, J., Galle, P.R., Merle, P., Hourmand, I.O., Cleverly, A., Zhao, Y., Gueorguieva, I., Lahn, M., Faivre, S., Benhadji, K.A., Giannelli, G.
Publicado 2019